0000950123-21-014094.txt : 20211105 0000950123-21-014094.hdr.sgml : 20211105 20211105165248 ACCESSION NUMBER: 0000950123-21-014094 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211105 DATE AS OF CHANGE: 20211105 EFFECTIVENESS DATE: 20211105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRV GP III, LLC CENTRAL INDEX KEY: 0001637299 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18417 FILM NUMBER: 211385312 BUSINESS ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617)585-2000 MAIL ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001637299 XXXXXXXX 09-30-2021 09-30-2021 false TRV GP III, LLC
Third Rock Ventures 29 Newbury Street, 3rd Floor Boston MA 02116
13F HOLDINGS REPORT 028-18417 N
Kevin Gillis Chief Operating Officer 617-585-2000 /s/ Kevin Gillis Boston MA 11-05-2021 3 7 526763 false 1 028-18439 Mark Levin 2 028-18438 Kevin P. Starr 3 028-18419 Robert I. Tepper
INFORMATION TABLE 2 6754.xml INFORMATION TABLE FOR FORM 13F DECIBEL THERAPEUTICS, INC. COM 24343R106 24207 3139685 SH DFND 1,2,3 3139685 0 0 FULCRUM THERAPEUTICS, INC. COM 359616109 139984 4962202 SH DFND 1,2,3 4962202 0 0 JOUNCE THERAPEUTICS, INC. COM 481116101 22652 3048780 SH DFND 1,2,3 3048780 0 0 NURIX THERAPEUTICS, INC. COM 67080M103 72580 2422549 SH DFND 1,2,3 2422549 0 0 PLIANT THERAPEUTICS, INC. COM 729139105 98565 5839160 SH DFND 1,2,3 5839160 0 0 REVOLUTION MEDICINES, INC. COM 76155X100 151966 5524031 SH DFND 1,2,3 5524031 0 0 VOYAGER THERAPEUTICS, INC. COM 92915B106 16809 6391176 SH DFND 1,2,3 6391176 0 0